The prevalence and clinical features of leflunomide‐associated peripheral neuropathy in patients with rheumatic disease in a New Zealand cohort.

MLA

Kaur, Gursimran, et al. “The Prevalence and Clinical Features of Leflunomide‐associated Peripheral Neuropathy in Patients with Rheumatic Disease in a New Zealand Cohort.” International Journal of Rheumatic Diseases, vol. 27, no. 9, Sept. 2024, pp. 1–7. EBSCOhost, https://doi.org/10.1111/1756-185X.15317.

APA

Kaur, G., Barclay, M., Mitchell, J., Jordan, S., & Stebbings, S. (2024). The prevalence and clinical features of leflunomide‐associated peripheral neuropathy in patients with rheumatic disease in a New Zealand cohort. International Journal of Rheumatic Diseases, 27(9), 1–7. https://doi.org/10.1111/1756-185X.15317

Chicago

Kaur, Gursimran, Murray Barclay, Joanne Mitchell, Sarah Jordan, and Simon Stebbings. 2024. “The Prevalence and Clinical Features of Leflunomide‐associated Peripheral Neuropathy in Patients with Rheumatic Disease in a New Zealand Cohort.” International Journal of Rheumatic Diseases 27 (9): 1–7. doi:10.1111/1756-185X.15317.